verona pharma merck - Search News

News

Merck shells out $10 billion for Verona

The Wall Street Journal on MSN · 4d

Merck to Buy Verona Pharma in $10 Billion Deal

The move bolsters Merck's lineup as it braces for the 2028 loss of patent exclusivity for blockbuster cancer drug Keytruda.

Reuters on MSN · 4d

Merck shells out $10 billion for Verona in bid to diversify beyond Keytruda

Merck said on Wednesday it will acquire UK-based Verona Pharma for about $10 billion, gaining a promising respiratory treatment as it faces pressure to diversify beyond its blockbuster cancer drug Keytruda.

MarketWatch on MSN · 4d

Merck dives into COPD treatments with $10 billion purchase of Verona Pharma

Merck & Co. Inc. is acquiring Verona Pharma PLC in a $10 billion deal that will expand the pharmaceutical giant’s portfolio of chronic obstructive pulmonary disease treatments with Verona Pharma’s Ohtuvayre.

2d

Merck's Verona Acquisition: Plugging A $4B Hole In A $20B Gap

Merck’s recent acquisition announcement sends a strong signal regarding its urgency to tackle the impending Keytruda patent ...

4d

Merck will have 'a lot more work to do' after Verona deal

Merck (MRK) is spending about $10 billion to acquire Verona Pharma (VRNA) as the company looks to fill future revenue gaps.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results